BRIEF published on 12/17/2025 at 09:35, 4 days 21 hours ago Topadur Pharma Appoints New CEO to Drive Growth CEO Appointment Clinical Development Topadur Pharma Dr. Matthias Schäfer Vascular Regeneration
BRIEF published on 12/17/2025 at 09:35, 4 days 21 hours ago Designated Person Notification by Aperam Share Transactions Aperam Market Abuse Luxembourg Stock Exchange Designated Person
BRIEF published on 12/17/2025 at 09:35, 4 days 21 hours ago Topadur Pharma nomme un nouveau PDG pour stimuler sa croissance Développement Clinique Nomination Du PDG Topadur Pharma Dr Matthias Schäfer Régénération Vasculaire
BRIEF published on 12/17/2025 at 09:35, 4 days 21 hours ago Notification de transaction d'une personne désignée chez Aperam Transparence Aperam Marché Boursier Règlement UE Personne Désignée
BRIEF published on 12/17/2025 at 09:35, 4 days 21 hours ago Notification de la personne désignée par Aperam Aperam Abus De Marché Bourse De Luxembourg Transactions Sur Actions Personne Désignée
BRIEF published on 12/17/2025 at 09:35, 4 days 21 hours ago Transaction notification from a designated person at Aperam Transparency Stock Market Aperam EU Regulation Designated Person
BRIEF published on 12/17/2025 at 09:26, 4 days 21 hours ago Heidelberg Pharma Faces Financial Hurdles Amid Strategic Adjustments Clinical Trials Cancer Research Cost-cutting Heidelberg Pharma Financial Challenges
BRIEF published on 12/17/2025 at 09:26, 4 days 21 hours ago Heidelberg Pharma confrontée à des difficultés financières dans un contexte d'ajustements stratégiques Essais Cliniques Réduction Des Coûts Heidelberg Pharma Défis Financiers Recherche Sur Le Cancer
BRIEF published on 12/17/2025 at 09:10, 4 days 22 hours ago Norgine Secures Licensing Deal with Vir Biotechnology for Hepatitis Delta Treatment Pharmaceuticals Licensing Agreement Norgine Vir Biotechnology Hepatitis Delta
BRIEF published on 12/17/2025 at 09:10, 4 days 22 hours ago Norgine conclut un accord de licence avec Vir Biotechnology pour le traitement de l'hépatite delta. Médicaments Contrat De Licence Norgine Vir Biotechnology Hépatite Delta
Published on 12/20/2025 at 00:30, 2 days 6 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 9 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 12 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 16 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 17 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/22/2025 at 07:00, 21 minutes ago VIB Vermögen AG sells logistics property in Großmehring
Published on 12/22/2025 at 04:30, 2 hours 50 minutes ago DFSK Officially Enters the Egyptian Market with Strategic Vehicle Lineup
Published on 12/22/2025 at 00:35, 6 hours 45 minutes ago Samsung to Host Series of Tech Forums at CES 2026
Published on 12/22/2025 at 00:05, 7 hours 15 minutes ago Samsung To Unveil AI Vision Built With Google Gemini at CES 2026
Published on 12/21/2025 at 08:55, 22 hours 25 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/19/2025 at 21:57, 2 days 9 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 22 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 22 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 3 days ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 3 days ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
